Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Wilma Minar"'
Publikováno v:
Clinical Lung Cancer. 9:S109-S115
Cytotoxic chemotherapy treatment for patients with advanced non–small-cell lung cancer (NSCLC) has reached a plateau, but further improvements are expected with integration of targeted therapies. Epidermal growth factor receptor (EGFR)–directed t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95bccd7930b324a6ac6ba14e3e8923df
https://doi.org/10.3816/clc.2008.s.016
https://doi.org/10.3816/clc.2008.s.016
Publikováno v:
Lung Cancer. 55:89-94
Anemia occurs frequently in patients with lung cancer receiving chemotherapy and has a negative impact on quality of life (QoL). Erythropoietic proteins effectively increase hemoglobin (Hb) levels, reduce transfusion requirements and improve QoL in a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::490ea18f89159a5c0bbf803e60fb4315
https://doi.org/10.1016/j.lungcan.2006.09.020
https://doi.org/10.1016/j.lungcan.2006.09.020
Publikováno v:
American Journal of Cancer. 4:233-245
Anemia has a high prevalence in patients with cancer. Its frequency and severity depend on tumor type, tumor stage, duration of disease, and treatment status. The etiology of cancer-related anemia is multifactorial and includes myelotoxicity of treat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::60a7c94625e1c4fe07de478dee29067a
https://doi.org/10.2165/00024669-200504040-00003
https://doi.org/10.2165/00024669-200504040-00003
Publikováno v:
Clinical Lung Cancer. 5:90-97
Anemia has a high prevalence in patients with lung cancer. Its frequency and severity depend on tumor stage, duration of disease, and previous and current treatment. Anemia affects the health-related quality of life and impacts prognosis and outcome
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62b4f017a4c13acd90e27ac9c7b477aa
https://doi.org/10.3816/clc.2003.n.022
https://doi.org/10.3816/clc.2003.n.022
Autor:
Robert, Pirker, Wilma, Minar
Publikováno v:
Frontiers of radiation therapy and oncology. 42
Patients with advanced NSCLC receive palliative chemotherapy with platinum-based doublets. Cisplatin-based doublets are preferred in patients with good performance status, whereas carboplatin-based protocols are preferred in patients with impaired or
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::00f84d67596ec63c02a3c4b33e0f0e90
https://pubmed.ncbi.nlm.nih.gov/19955802
https://pubmed.ncbi.nlm.nih.gov/19955802
Autor:
Robert Pirker, Wilma Minar
Patients with advanced NSCLC receive palliative chemotherapy with platinum-based doublets. Cisplatin-based doublets are preferred in patients with good performance status, whereas carboplatin-based protocols are preferred in patients with impaired or
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a17d57f0ec45081cf10113015bb29f9a
https://doi.org/10.1159/000262471
https://doi.org/10.1159/000262471
Autor:
G. Krajnik, Franz Eckersberger, Susanne Schmeikal, Rolf-Michael Müller, Robert Pirker, Wilma Minar, Gudrun Pohl, Boris Pokrajac, Walter Klepetko, Gerhard Ambrosch, Cornelia Schäfer-Prokop, Alfred Maier, Reza Malayeri, Michael Woltsche
Publikováno v:
Lung cancer (Amsterdam, Netherlands). 54(1)
Summary Induction chemotherapy may improve clinical outcome of locally advanced non-small cell lung cancer (NSCLC). To further pursue this, the Austrian Association for the Study of Lung Cancer (AASLC) performed a multi-center phase II trial with TIP
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::982ba9971d092c715adf4c09139dd93a
https://pubmed.ncbi.nlm.nih.gov/16926060
https://pubmed.ncbi.nlm.nih.gov/16926060
Publikováno v:
Lung Cancer. 49:S340-S341
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2f20483cd72e192946a774b39de3b0d0
https://doi.org/10.1016/s0169-5002(05)81333-9
https://doi.org/10.1016/s0169-5002(05)81333-9
Autor:
Lilian Doweik, Katrin Wiesenberger, Wilma Minar, Gudrun Pohl, Robert Pirker, G. Krajnik, Reza Malayeri
Publikováno v:
Lung Cancer. 41:S276-S277
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::129b3731268af67228d30e6c7166064a
https://doi.org/10.1016/s0169-5002(03)92700-0
https://doi.org/10.1016/s0169-5002(03)92700-0
Autor:
Gudrun Pohl, Katrin Wiesenberger, Franz Eckersberger, Walter Klepetko, Rolf-Michael Müller, Gerhard Ambrosch, Alfred Maier, Michael Woltsche, Wilma Minar, Robert Pirker
Publikováno v:
Lung Cancer. 41:S224
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ed092e7394e79bb28f2386587b96bd7f
https://doi.org/10.1016/s0169-5002(03)92492-5
https://doi.org/10.1016/s0169-5002(03)92492-5